These findings show that ETS1 is contributing to the lymphomagenesis in a subset of DLBCL and identifies FCMR as a novel target of ETS1, predominantly expressed in ABC-DLBCL. The gene discussed is FCMR; the disease is diffuse large B-cell lymphoma.